Have you ever stared at a private company that everyone in tech keeps whispering about and thought, I would love a sliver of that, except the door is locked? That is the itch a new listed vehicle is trying to scratch. A well-known technology bull is preparing a closed-end fund that promises everyday investors a seat near late-stage firms helping build the artificial intelligence stack. The headline number is tidy. Twenty million shares at ten dollars each. Two hundred million dollars in gross proceeds. The listing venue is the New York Stock Exchange. The proposed ticker is IVAI. On paper it looks like a bridge. In practice it is a product with fees, valuation gaps, and a very particular idea of what “access” really means.
Why A Listed Vehicle For Private AI Names Matters Now
I have watched this debate for years. Public markets give you Nvidia, Microsoft, and a handful of obvious winners. Private markets hold the labs, the tooling firms, the data-center specialists, and the infrastructure shops that never show up in a standard brokerage screener. Plenty of people feel shut out. A survey of more than two thousand adults, commissioned earlier this year by a capital-raising platform, found that about two-thirds of Americans believe they cannot reach the highest-growth private companies. A little more than half said they no longer see the stock market as the best place to build wealth, even after a year of record indexes. That combination of FOMO and skepticism is rocket fuel for a product like this.
The manager behind the launch is Dan Ives, long associated with bullish technology research and now a partner at Yorkville Ives and Company. He left a high-profile research desk in July and is putting his name on the door of a fund that will try to bottle the private side of the AI buildout. His line is blunt. In this cycle, many of the companies that matter will stay private for longer. He wants a public wrapper around that reality.
In this AI revolution, so many of the companies leading it will be private. The idea is a public vehicle to buy some of these great private companies.
– Fund sponsor, discussing the product thesis
That quote is marketing, of course. Still, the underlying point is not crazy. Capital intensity in model training, power, networking, and specialized chips has exploded. A lot of the spending sits with firms that are not listed. If you only own public megacaps, you own the visible layer. You do not own every pick-and-shovel name underneath. Whether a closed-end fund is the cleanest way to close that gap is another question. I will come back to fees and discounts. First, the structure.
What The Ives Ultra AI Opportunities Fund Is Built To Hold
According to the filing language that has circulated with the launch, roughly 80 percent of net assets is earmarked for companies centered on AI. The emphasis is private late-stage AI companies in the United States, with a smaller sleeve for non-U.S. names, plus publicly traded U.S. companies. Up to 15 percent of the portfolio may sit in private funds that themselves own AI exposure. That last sleeve is easy to miss and worth circling. You are not only buying operating companies. You may also be buying funds that buy companies. Layering is not automatically bad. It is extra cost and extra opacity.
The product is a closed-end fund, not an open-end mutual fund and not a garden-variety ETF. That distinction matters more than the ticker. In a closed-end structure, the manager raises a pool of capital, lists the shares, and then the share price floats on its own. Net asset value and market price can drift apart. Sometimes you get a premium. More often, over a full cycle, you see a discount. If you buy at ten dollars because that is the IPO price, you are not guaranteed that the market will treat ten dollars as fair value six months later.
Total annual expenses are slated around 3.1 percent on gross assets. Let me say that slowly. Three point one percent. In a world where vanilla index products charge a few basis points, that is a heavy toll. You can justify it if the private book is genuinely scarce and the underwriting is excellent. You cannot justify it if the book looks like a closet of late-stage rounds that later-stage venture already picked over. I am not calling the winner yet. I am saying the hurdle rate just got higher before the first position is even marked.
The Retail Access Story And Why It Resonates
Ives has said investors keep asking how to get exposure to private firms driving the AI buildout. That tracks with what I hear from readers. People do not want another mega-cap wrapper. They want the names that show up in conference-hall gossip. They want the training-cluster vendors, the inference-optimization shops, the power-procurement specialists, the data-labeling platforms that still refuse to list. The emotional pitch writes itself. It should not only be a handful of people on the West Coast who get to own those businesses.
Fair enough. Access is a real issue. Accredited-investor rules, minimum checks, and long lockups keep most households out. A listed share that trades during market hours feels like a solution. It is also a compromise. You get liquidity of the fund share, not liquidity of the underlying private stock. If a late-stage round is marked quarterly with a lag, the fund’s NAV can be stale while the ticker whips around on headlines. That is not a bug unique to this product. It is the nature of mixing public trading with private marks.
- Public share liquidity is not the same as private-asset liquidity.
- Valuations on late-stage rounds can sit still for months, then jump in a single funding event.
- A closed-end ticker can trade at a premium when the story is hot and a discount when the story cools.
- Fees compound whether the private book is soaring or stuck in a flat mark.
In my experience, the investors who do well with vehicles like this treat them as a satellite, not a core holding. They size it small. They assume the discount can widen. They read the annual report like a skeptic, not a fan. That is not cynicism. That is hygiene.
Private Companies As The So-Called Golden Goose
Ives has called private companies the golden goose of the next wave of AI spending. Colorful. Also partly true. Model developers have been burning cash at a pace that would have looked absurd a decade ago. Someone has to sell them chips, networking gear, cooling, power contracts, evaluation tools, safety layers, and enterprise wrappers. A chunk of that supply chain is still private. If those firms later list, early owners can look like geniuses. If they stay private and keep marking up, the fund can show paper gains that never quite convert into cash until an exit appears.
There is a timing wrinkle. Leading developers have flirted with public listings. Confidential filings have been discussed in the industry all year. At the same time, at least one high-profile chief executive has poured cold water on a 2026 IPO, pointing to the messy debate over safety guardrails. That is the texture of this market. The narrative flips. One week it is acceleration. The next week it is pause, regulation, power shortages, or circular vendor financing. Ives himself said there are twists and turns and that investors should not get lost in negative narratives. I agree that narratives overshoot. I also think ignoring them is how people overpay for access.
There is a lot of twists and turns going on in the AI trade. Do not get lost in the negative narratives.
Perhaps the most interesting aspect is not the cheerleading. It is the admission that the public tape no longer captures the whole machine. That used to be a venture-capital talking point. Now it is a product feature.
Fees, Structure, And The Math You Should Run Before You Click Buy
Let us talk about the unromantic part. A 3.1 percent expense load on gross assets is not a rounding error. If the private book compounds at a spectacular rate, you may not care. If the book compounds at a merely decent rate, the fee eats the edge. Closed-end funds also have a habit of issuing at NAV-ish prices and then settling into a discount once the IPO pop fades. That pattern is not destiny. It is a tendency. Tendencies matter when you are the one supplying the capital.
| Item | Stated Feature | Investor Question |
| Share sale | 20 million shares at $10 | Will the aftermarket hold $10? |
| Gross proceeds | $200 million | Is that enough scale for a diversified private book? |
| Expense load | About 3.1% on gross assets | What net return is required to beat a simple public AI basket? |
| Private focus | ~80% AI-centered names | How late-stage, and how concentrated? |
| Fund-of-funds sleeve | Up to 15% | Are you paying two layers of fees? |
| Listing | NYSE, ticker IVAI | Liquidity of the share, not the holdings |
Run a boring comparison. Suppose a liquid basket of public AI infrastructure names costs you almost nothing and compounds at a mid-teens rate over a long stretch. Your private vehicle needs to clear that rate after fees, after any discount, and after the extra volatility of stale marks. That is a high bar. It is not impossible. Late-stage winners have printed enormous outcomes. It is just not automatic because the word private sounds exclusive.
I have found that people confuse exclusivity with edge. They are not the same. A company can be private and still be richly priced. A round can be late-stage and still be a crowded trade among the same ten funds. If everyone who matters already owns the name, you are not early. You are the liquidity for someone who wants a mark and a story.
How This Fits Beside Public AI Winners
Nobody serious is arguing that public champions disappear. The listed giants still capture enormous cash flow from cloud, chips, and software distribution. What the new fund is selling is complementarity. Own the household names in a regular brokerage account. Use a satellite sleeve for the private layer you cannot buy directly. That framing is cleaner than “this replaces your entire AI allocation.” It also keeps position size honest.
There is another angle. Public multiples can get stretched when every narrative fund piles into the same five tickers. Private marks can look calmer because they do not print every second. Calm is not the same as cheap. A private mark that only updates when a friendly round lands can hide a lot of weather. If power costs spike, if a model lab slashes capex, if a safety rule lands harder than expected, the public names gap down immediately. The private book may take a quarter to admit it.
- Decide what problem you are actually solving: access, diversification, or narrative.
- Size the position as if the ticker can sit 15 to 20 percent below NAV in a sour tape.
- Read how the manager will value illiquid holdings and how often those marks refresh.
- Ask whether the 15 percent private-fund sleeve stacks fees on fees.
- Compare expected net returns with a low-cost public infrastructure basket.
None of that is exciting. It is how you avoid becoming the exit liquidity for a good story.
Safety Debates, Slowdown Talk, And Why The Calendar Still Matters
The fund arrives while the industry argues with itself. Some researchers want a slower cadence. Some labs want more guardrails. Some policymakers want audits. Some energy grids want a nap. Ives argues that those appeals should not scare long-term investors away from the sector’s viability. I partly agree. The buildout is not a weekend hobby. Enterprises are embedding models into workflows. Capex plans are multi-year. A pause in one lab’s IPO calendar is not the same as a collapse in demand for compute.
Still, viability and valuation are cousins, not twins. A sector can be viable and over-owned. A company can be essential and still raise at a price that assumes perfection. When a closed-end product markets “the companies leading the revolution,” the implied promise is selection skill. Selection skill is hard when the best names are already courted by giant private pools. That is the quiet risk. Not that AI fails. That the fund pays up for access that is less exclusive than the brochure suggests.
Rhetorical question, and I mean it: if the golden goose is so obvious, why is a listed wrapper with a fat fee the only way for you to touch it? Sometimes the answer is regulation and check size. Sometimes the answer is that the easy money already left the room.
Who This Product Is For, And Who Should Walk Past It
I would sketch two portraits. The first is a long-horizon investor who already owns public tech, understands closed-end discounts, can tolerate stale NAVs, and wants a small satellite in private AI. That person can underwrite the fee if the book is concentrated in real operators rather than concept slides. The second is a newcomer who hears “private AI” and thinks lottery ticket. That person should not be first in line at the IPO window.
Closed-end IPOs have a social dynamic. Friends text friends. The ticker feels like a club. Then the aftermarket does what aftermarkets do. If you cannot live with a drawdown that has nothing to do with the underlying companies and everything to do with fund-flow mechanics, skip the opening print. Wait. Watch the discount. Read the first holdings report. Boring advice. Good advice.
A simple mental model I keep on a sticky note: Access is not edge. Liquidity of the share is not liquidity of the asset. A 3% fee is a claim on future magic. Discounts are a feature of the wrapper, not a moral failing of the manager.
Keep that nearby when the marketing deck starts talking about revolutions. Revolutions are expensive. Wrappers are optional.
Portfolio Construction Without The Mystique
If you still want in, build around the fund rather than through it. Hold your public chip, cloud, and software winners in cheap vehicles. Use cash or short-duration ballast so you are not forced to sell the closed-end share into a discount. Revisit the position when the first full portfolio snapshot lands. Look for concentration. Look for related-party funds. Look for marks that only move when friendly capital arrives. That is the work. The ticker is the easy part.
I also like a written rule. Something like: no more than a single-digit percentage of liquid net worth in vehicles that mix public trading with private marks. Write it down before the first green candle. People get sloppy when a story feels historic. Historic stories still have bid-ask spreads.
Another practical habit. Separate the research personality from the product. A sharp strategist can be right on the decade and still launch a vehicle that is expensive for the decade. You can agree with the secular case and decline the wrapper. That is allowed. In fact, it is how grown-ups invest.
What “Late-Stage” Quietly Implies
Late-stage sounds safer than seed. Sometimes it is. Revenue exists. Customers exist. The pitch deck has fewer cartoons. Late-stage also means the valuation already embeds a lot of triumph. You are not backing a garage. You are buying a company that has already collected sophisticated money. The remaining upside has to come from scale, listing, or a strategic sale. Those paths are real. They are also crowded with terms that favor earlier holders.
Watch preference stacks. Watch secondary volume. Watch whether the fund is buying primary paper, meaning new shares that fund the company, or secondary paper, meaning someone else is selling. Primary can support growth. Secondary can be a transfer of risk from an insider to you. Both can be fine. You deserve to know which one you are funding.
I have sat through enough late-stage processes to know the room temperature. Everyone is polite. Everyone is “long-term.” Everyone wants a mark that defends last quarter’s narrative. A listed fund walking into that room with two hundred million dollars is not a giant. It is a guest. Guests do not always get the best allocation.
The Cultural Moment Behind The Product
Zoom out. Households watched a handful of public winners run. They also watched private names become dinner-table brands without ever offering a share. That gap breeds products. It also breeds politics. People want inclusion. Managers want AUM. Exchanges want listings. The alignment is obvious. The alignment is not the same as a free lunch.
There is a softer point I keep coming back to. Democratizing access is a good sentence. Democratizing risk is the companion sentence nobody puts on the cover. Private assets can be wonderful. They can also sit in a fog for years. If your timeline is a mortgage refinance or a tuition bill, fog is not a strategy. Match the wrapper to the calendar of your life, not the calendar of a keynote speech.
It should not just be a handful of people who get to own the companies building the next computing layer. Agreed. It also should not be a handful of slogans that replace homework.
A Clear-Eyed Close, Without The Victory Lap
So here we are. A recognizable technology bull is putting his name on a closed-end fund aimed at private, late-stage AI and related infrastructure. The raise targets two hundred million dollars. The share count is twenty million at ten dollars. The listing plan points to a familiar exchange and a short ticker. The book will lean hard into AI-centered private names, with room for public U.S. stocks and a sleeve of private funds. The fee is not shy. The story is not shy either.
I do not think the secular demand for compute is a mirage. I do think access products deserve the same cold reading you would give any other packaged idea. Look at structure first. Look at cost second. Look at valuation discipline third. Look at the manager’s actual ability to win allocations fourth. The brand comes last, even when the brand is good at television.
If you buy, buy because the portfolio construction fits a hole you can describe in one sentence. If you pass, pass without feeling like you missed a secret door. There will be other doors. Some will be cheaper. Some will be listed after the first wave of marks has been stress-tested by a sloppy tape. Patience is not the opposite of ambition. It is how ambition survives contact with fees.
And if you remember only one thing from this long walk through a short prospectus story, make it this. Private is a legal status. It is not a guarantee of outperformance. Treat the ticker as a tool. Treat the narrative as advertising. Then decide, with your own time horizon in mind, whether the golden goose is worth the cage it comes in.
